GDRX
GoodRx Holdings
Is GDRX Halal?
Prescription savings platform with permissible business model.
What You Should Know
GoodRx provides prescription drug price comparison and coupons. Business model is halal, low debt, acceptable Sharia compliance. Its March 31, 2026 Form 10-Q reports $2,021.251 million of assets, $487.422 million of interest-bearing debt, $235.710 million of cash, $232.721 million of receivables and $194.006 million of quarterly revenue. Debt/assets is 24.11%, liquidity/assets is 11.66%, receivables-plus-cash/assets is 23.18% and disclosed interest income is 0.72% of revenue; the examined FTSE, MSCI and Malaysia asset ratios pass.
⚠️ Concerns
- •Prescription reimbursement assets and liabilities
- •Advertising and pharmacy-partner relationships
- •Interest-bearing debt
- •Interest income
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-03-31; calculated 2026-07-15.
487.422 / 2,021.251
235.71 / 2,021.251
468.431 / 2,021.251
1.397 / 194.006
- Financial
- Pass
- Overall
- Pass
Debt/assets is 24.11%, liquidity/assets is 11.66%, receivables-plus-cash/assets is 23.18% and disclosed interest income is 0.72% of revenue; examined FTSE financial ratios and core activity pass.
- Financial
- Pass
- Overall
- Pass
Debt/assets is 24.11%, liquidity/assets is 11.66% and receivables-plus-cash/assets is 23.18%, below the examined MSCI total-assets limits; this is not an index-membership claim.
- Financial
- Pass
- Overall
- Pass
Debt/assets and liquidity/assets pass the examined Malaysia limits; this is a calculation against SAC ratios, not an official classification.
- Financial
- Not calculated
- Overall
- Incomplete
A properly licensed and reproducible historical market-cap series is not stored; filing-based financial results remain documented.
Business-activity disclosure
GoodRx provides prescription price comparison, coupons, telehealth and healthcare-navigation services. The core healthcare-information activity is generally permissible.
Limitation: The filing does not classify every advertising partner, prescription product, pharmacy relationship or downstream use; no unsupported prohibited-revenue percentage is invented.
Purification
GoodRx discloses $1.397 million of interest income, but does not provide a scholar-approved purification percentage or a separate prohibited-activity numerator.
Inputs, assumptions and primary sources
- Amounts are USD millions converted from GoodRx's March 31, 2026 Form 10-Q values reported in thousands.
- Interest-bearing debt is $5.000 million of current debt plus $482.422 million of debt, net; operating lease liabilities are excluded.
- Cash and cash equivalents are $235.710 million; prescription reimbursement assets are operating working-capital assets and no separate interest-bearing securities balance is identified.
- Accounts receivable are $232.721 million, quarterly revenue is $194.006 million and disclosed interest income is $1.397 million.
- Prescription price comparison, coupons and healthcare navigation are generally permissible, while advertising partners, prescription products and customer uses require qualitative review.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →